Following AAFA's first poll in 2010 showing that the majority of asthma, allergy, cold and flu patients opposed changing popular OTC medications to Rx status, the nonprofit patient organization worked with Harris Interactive to conduct a 2013 follow-up study to look more into the burdens that patients face. The results show that a clear majority (62%) of patients are opposed to Rx-only restrictions. Additionally, AAFA's 2013 study looked beyond the original set of questions asked in 2010 to gain a better understanding of burdens patients currently face and how those burdens would be impacted by a PSE prescription requirement.
Survey results show that patients already face costs and burdens associated with treating their common symptoms.
•Two-thirds of patients (64%) say they are managing medications for 2 or more people in their household
•Patient households deal with allergy symptoms for more than 2 months per year (69.5 days on average)
•Only 1-in-five patients can get in to see their doctor the same day, with nearly one quarter (22%) having to wait more than a week to get an appointment
•Patients say that two in five (42%) of their visits to the doctor require time off of work, with one-third (31%) saying that their doctor visits always take place during their work hours
•When including drive time, waiting-room time and the visit itself, only 1-in-five patients surveyed spend less than an hour when visiting the doctor, with nearly one-third (30%) requiring 2 or more hours per visit; one-in-ten (9%) require 3 or more hours per visit
•The majority of patients surveyed (59%) spend at least $20 per doctor visit, plus 4-out-of-5 of them (82%) are also paying to fill prescriptions frequently or occasionally for themselves or family members
AAFA has posted more information online for the public and policymakers at www.aafa.org/pse so people can learn what to do in their own states to fight meth while also preserving access to OTC medications.
"Patients are really concerned about extreme local laws that limit their freedom to access meds," says Collins. "AAFA is working with patients nationwide to teach lawmakers about better solutions. We want to make sure that the patient voice is heard."
About the Survey
AAFA's National Pseudoephedrine (PSE) Awareness Study was conducted online between January 4 - 15, 2013 among 2,020 U.S. adults age 18+ who personally suffered from asthma, allergies, cold, cough or flu in the preceding 12 months and purchased non-prescription medications for at least one condition during that time. The poll was conducted for AAFA by Harris Interactive, supported by a grant from the Consumer Healthcare Products Association (CHPA). The study used Harris Interactive's proprietary propensity weighting to ensure the online sample reflects general population trends.
The Asthma and Allergy Foundation of America (AAFA), a not-for-profit organization founded in 1953, is the leading patient organization for people with asthma, allergies and related conditions. AAFA is dedicated to improving the quality of life for patients through education, advocacy and research. AAFA provides practical information, community based services and support through a network of regional chapters, support groups and other local partners around the United States. For more information, visit www.aafa.org.
About Harris Interactive
Harris Interactive is one of the world's leading custom market research firms, leveraging research, technology, and business acumen to transform relevant insight into actionable foresight. Known widely for the Harris Poll and for pioneering innovative research methodologies, Harris offers expertise in a wide range of industries including healthcare, technology, public affairs, energy, telecommunications, financial services, insurance, media, retail, restaurant, and consumer package goods. Serving clients in over 215 countries and territories through our North American, European, and Asian offices and a network of independent market research firms, Harris specializes in delivering research solutions that help us -- and our clients -- stay ahead of what's next. For more information, please visit www.harrisinteractive.com.
Embedded Video Available
Image Available: http://www2.marketwire.com/mw/frame_mw?attachid=2238488
Embedded Video Available: http://www2.marketwire.com/mw/frame_mw?attachid=2238522
Add to Digg Bookmark with del.icio.us Add to Newsvine
Most Popular Stories
- Updates on Everglades' Stranded Pilot Whales
- Hezbollah Chief's Assassination Claimed by Sunni Group
- Stolen Cobalt-60 Recovered in Mexico
- Wind Power and Wildlife Can Coexist
- Ford Mustang Still Packs Power
- Sarmiento to Handle Greeley Latin Ops
- Allstate Seeks to Invest in Minority Firms
- First-time Jobless Claims Drop Below 300,000
- White House Pushes to Extend Unemployment Benefits
- Elizabeth Warren Ends 2016 Presidential Rumors